摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-chloro-2-methoxy-5-nitrobenzoic acid | 68255-77-6

中文名称
——
中文别名
——
英文名称
4-chloro-2-methoxy-5-nitrobenzoic acid
英文别名
2-methoxy-4-chloro-5-nitrobenzoic acid;4-chloro-5-nitro-o-anisic acid;4-Chlor-2-methoxy-5-nitro-benzoesaeure
4-chloro-2-methoxy-5-nitrobenzoic acid化学式
CAS
68255-77-6
化学式
C8H6ClNO5
mdl
——
分子量
231.592
InChiKey
RSBXOVZBSUWTCT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    92.4
  • 氢给体数:
    1
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2918990090

SDS

SDS:2ffbc9735c58a4826ce70b1fbecba53c
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    N-(3-pyrrolidinyl) benzamide derivative
    摘要:
    以下一般式(I)代表的N-(3-吡咯基)苯甲酰衍生物具有对多巴胺D.sub.3和/或D.sub.4受体的强效选择性拮抗作用,可用作精神药物、治疗精神分裂症的药物等,或其药学上可接受的盐或药物制剂。
    公开号:
    US05686482A1
  • 作为产物:
    参考文献:
    名称:
    Progress and records in the study of endogenetic mineralization during collisional orogenesis
    摘要:
    To develop and perfect the theory of plate tectonics and regional metallogeny, metallogenesis during collisional orogenesis should be thoroughly studied and wilt attract increasing attention of more and more scientists. This paper presents the main aspects of research and discussions on metallogenesis during collisional orogenesis after the development of plate tectonics, and accordingly divides the study history into two stages, i.e. the junior stage during 1971-1990 and the senior stage after 1990. Beginning with the negation of mineralization in the collision regime by Guild (1971), the focus of study was put on whether there occurred any mineralization during collisional orogenesis at the junior stage. At the senior stage, which is initiated by the advance of metallogenic and petrogenic model for collisional orogenesis, scientists begin to pay their attention to the geodynamic mechanism of metallogenesis, spatial and temporal distribution of ore deposits, ore-forming fluidization, relationship between petrogenesis and mineralization in collisional orogenesis, etc, Abundance of typical collisional orogens such as Himalayan, China has best natural conditions to study collisional metallogenesis. Great progress in the study of metallogenesis during collisional orogenesis has been made by Chinese geologists. Therefore, we hope that the Chinese geologists and Chinese governments at various levels to pay more attention to the study of collisional metallogenesis. Some urgent problems are suggested to be solved so as to bring about breakthroughs in the aspects concerned.
    DOI:
    10.1007/bf02884893
点击查看最新优质反应信息

文献信息

  • Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides
    作者:Shiro Kato、Toshiya Morie、Katsuhiko Hino、Tatsuya Kon、Shunsuke Naruto、Naoyuki Yoshida、Tadahiko Karasawa、Junichi Matsumoto
    DOI:10.1021/jm00167a020
    日期:1990.5
    With the purpose of obtaining more potent and selective gastric prokinetic than metoclopramide (1), a new series of N-[(2-morpholinyl)alkyl]benzamides (17-52) were synthesized and their gastric prokinetic activity was evaluated by determining effects on the gastric emptying of phenol red semisolid meal and of resin pellets solid meal in rats and mice. The morpholinyl moiety was newly designed after
    为了获得比甲氧氯普胺(1)更有效和选择性的胃动力,合成了一系列新的N-[(2-吗啉基)烷基]苯甲酰胺(17-52),并通过测定对胃泌素的作用来评估其胃动力。大鼠和小鼠胃中酚红半固体粉和树脂颗粒固体粉的胃排空。考虑到西沙必利(2)的侧链结构后,新设计了吗啉基部分,并与甲氧氯普胺和西沙必利的4-氨基-5-氯-2-甲氧基苯甲酰基偶联时产生了所需的活性。苯甲酰基的取代基的改性显着影响了活性。特别是,
  • [EN] FUSED TRI AND TETRA-CYCLIC PYRAZOLE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE PYRAZOLE KINASE FUSIONNEE TRICYCLIQUE ET TETRACYCLIQUE
    申请人:ABBOTT LAB
    公开号:WO2004080973A1
    公开(公告)日:2004-09-23
    Compounds having the formula (I) (I), are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
    具有化学式(I) (I)的化合物对抑制蛋白激酶很有用。还公开了制备这些化合物的方法、含有这些化合物的组合物,以及使用这些化合物进行治疗的方法。
  • Benzopiperidine derivatives
    申请人:Eisai Co., Ltd.
    公开号:US06518423B1
    公开(公告)日:2003-02-11
    Benzopiperidine derivatives represented by formula (I), salts thereof or hydrates thereof, processes for producing the same and drugs comprising the same: wherein the variables are as described in the specification. These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and rejection reaction accompanying organ transplantation.
    本茨哌啶衍生物,由公式(I)表示,其盐或水合物,其制备方法以及包含其的药物: 其中变量如说明书中所述。这些化合物作为药物有效,用于预防和治疗这些各种炎症性疾病和免疫性疾病,如类风湿性关节炎、特应性皮炎、银屑病、哮喘和伴随器官移植的排斥反应。
  • 4-(aroylamino)piperidine-butanimide derivatives
    申请人:Janssen Pharmaceutica
    公开号:US04990521A1
    公开(公告)日:1991-02-05
    A method of treating warm-blooded animals suffering from diarrhea, which method comprises the administration of particular 4-(aroylamino)piperidinebutanamide derivatives and compositions containing the same. Novel 4-(aroylamino)piperidinebutanamide derivatives.
    一种治疗患有腹泻的温血动物的方法,该方法包括给予特定的4-(芳酰氨基)哌啶丁酰胺衍生物和包含相同成分的制剂。新型的4-(芳酰氨基)哌啶丁酰胺衍生物。
  • 3-QUINOLINE-2-(1H)-YLIDENEINDOLIN-2-ONE DERIVATIVES
    申请人:YAMANOUCHI PHARMACEUTICAL CO. LTD.
    公开号:EP1396490A1
    公开(公告)日:2004-03-10
    There is provided medicaments, particularly a vascular endothelial growth factor (VEGF) inhibitor which is useful as a therapeutic drug for solid tumors, diabetic retinopathy and the like diseases in which angiogenesis is taking a role. That is, since a novel 3-quinolin-2(1H)-ylideneindolin-2-one derivative or a salt thereof has good VEGF inhibitory action, angiogenesis inhibitory action and anti-tumor action, it is useful as ideal VEGF inhibitor, angiogenesis inhibitor and anti-tumor agent.
    提供了药物,特别是一种血管内皮生长因子(VEGF)抑制剂,它可作为固体肿瘤、糖尿病视网膜病变等疾病的治疗药物,这些疾病中血管生成起着作用。也就是说,由于一种新型的3-喹啉-2(1H)-基吲哚-2-酮衍生物或其盐具有良好的VEGF抑制作用、血管生成抑制作用和抗肿瘤作用,因此它可作为理想的VEGF抑制剂、血管生成抑制剂和抗肿瘤药剂。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐